Valuation : EirGenix Inc.

Market Cap 1.52TCr 48Cr 41Cr 39Cr 35Cr 67Cr 4.58TCr 67Cr 456.66Cr 178.52Cr 2.31TCr 180.17Cr 176.27Cr 7.64TCr P/E 2026 *
-33x
P/E 2027 * 88.1x
Enterprise Value 1.4TCr 44Cr 38Cr 35Cr 32Cr 61Cr 4.21TCr 61Cr 419.21Cr 163.87Cr 2.12TCr 165.39Cr 161.82Cr 7.02TCr EV / Sales 2026 *
9.47x
EV / Sales 2027 * 6.13x
Free-Float
59.94%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week+2.05%
Current month+10.81%
1 month+8.99%
3 months+18.47%
6 months-18.52%
Current year-19.45%
1 week 49.3
Extreme 49.3
53
1 month 44.3
Extreme 44.3
53
Current year 40.15
Extreme 40.15
67.6
1 year 40.15
Extreme 40.15
84.3
3 years 40.15
Extreme 40.15
111
5 years 40.15
Extreme 40.15
163.5
10 years 21.55
Extreme 21.55
195
Manager TitleAgeSince
Chief Executive Officer - 01/04/2013
Director of Finance/CFO - 03/05/2016
Corporate Officer/Principal - 20/05/2019
Director TitleAgeSince
Director/Board Member - 14/06/2013
Director/Board Member - 13/09/2016
Chairman - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%+2.05%-19.19%-46.67% 48Cr
-0.87%-2.29%+37.61%-2.73% 8.07TCr
-4.60%+7.09%+468.80%+27.55% 5.7TCr
-1.11%+3.28%-20.09%-35.83% 5.99TCr
+0.76%+3.53%+0.08%+36.18% 5.33TCr
+0.41%+1.84%+10.29%+171.67% 4.93TCr
+0.19%+3.34%+62.44%-16.23% 3.27TCr
-0.30%+0.41%+50.57%+100.03% 2.59TCr
+0.09%+4.98%+18.59%+209.35% 2.39TCr
+0.78%+0.47%+61.53%+123.40% 1.71TCr
Average -0.19%+2.20%+67.06%+56.67% 4TCr
Weighted average by Cap. -0.24%+2.10%+84.70%+46.82%

Financials

2026 *2027 *
Net sales 147.4Cr 4.65Cr 3.99Cr 3.74Cr 3.42Cr 6.45Cr 444.31Cr 6.47Cr 44Cr 17Cr 223.93Cr 17Cr 17Cr 741.11Cr 234.3Cr 7.39Cr 6.35Cr 5.94Cr 5.44Cr 10Cr 706.25Cr 10Cr 70Cr 28Cr 355.94Cr 28Cr 27Cr 1.18TCr
Net income -46Cr -1.45Cr -1.24Cr -1.16Cr -1.06Cr -2Cr -138.05Cr -2.01Cr -14Cr -5.38Cr -70Cr -5.43Cr -5.31Cr -230.28Cr 17Cr 54.28L 46.6L 43.63L 39.95L 75.25L 52Cr 75.47L 5.17Cr 2.02Cr 26Cr 2.04Cr 1.99Cr 86Cr
Net Debt -124.7Cr -3.94Cr -3.38Cr -3.16Cr -2.9Cr -5.46Cr -375.88Cr -5.47Cr -37Cr -15Cr -189.44Cr -15Cr -14Cr -626.98Cr -84Cr -2.64Cr -2.27Cr -2.13Cr -1.95Cr -3.67Cr -252.6Cr -3.68Cr -25Cr -9.84Cr -127.31Cr -9.93Cr -9.72Cr -421.34Cr
Logo EirGenix Inc.
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Employees
1,000
Date Price Change Volume
27/26/27 NT$50.20 -0.59% 3,64,960
26/26/26 NT$50.50 +1.61% 4,50,509
25/26/25 NT$49.70 -1.19% 4,32,331
24/26/24 NT$50.30 -1.76% 5,14,086
21/26/21 NT$51.20 -0.78% 7,28,147
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
50.20TWD
Average target price
111.00TWD
Spread / Average Target
+121.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6589 Stock